Results

Total Results: 272 records

Showing results for "end stage renal".

121. Peripheral-Artery-Disease-Treatment Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
     January 31, 2013 - shares similar risk factors: male gender, age, diabetes, smoking, hypertension, high cholesterol, and renal … Fontaine classification Stage I No symptoms Stage IIa Intermittent claudication > 200m of walking … Stage 3 Rest pain Stage 4 Necrosis/gangrene Table 2. … Rutherford classification Stage 0 Asymptomatic Stage 1 Mild claudication Stage 2 Moderate claudication … Stage 3 Severe claudication Stage 4 Rest pain Stage 5 Ischemic ulceration not exceeding ulcer of

122. Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
     December 01, 2012 - To that end, advances in molecular and genomic medicine, such as gene expression profiling, may improve … underestimation of the tumor genomic landscape from analysis of multiple samples from patients with primary renal … 1) and stage D (Stage IV) colorectal cancer. … A or stage D. … T-stage, N-stage and MSI status.

123. Treatment Strategies for Patients With Peripheral Artery Disease (PAD) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/peripheral-artery-disease-treatment/research-protocol
     December 01, 2019 - shares similar risk factors: male sex, older age, diabetes, smoking, hypertension, high cholesterol, and renal … Fontaine classification Stage I No symptoms Stage IIa Intermittent claudication >200 … moderate to severe) Stage 3 Rest pain Stage 4 Necrosis/gangrene Table 2. … Rutherford classification Stage 0 Asymptomatic Stage 1 Mild claudication Stage … 2 Moderate claudication Stage 3 Severe claudication Stage 4 Rest pain Stage 5

124. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
     January 10, 2012 - Adjunct for the prevention of rejection in renal homotransplantation; management of active rheumatoid … (Hoffmann-La Roche) Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac … Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac, or hepatic transplants … Key Informants Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

125. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
     January 07, 2016 - On page 20 lines 5-13, this topic is finally broached at the end of the "Future Research" section. … We know that CIN incidence varies dramatically based on baseline renal function, and the absence of … contrast-induced nephropathy (CIN), for the outcomes of incidence of CIN, chronic kidney disease (CKD), end … stage renal disease (ESRD), mortality, and other adverse events? … Need for renal replacement therapy is addressed in all comparisons.

126. Diabetes-Foot-Ulcer-Amputation-Prevalence Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
     February 01, 2011 - Those with diabetes are expected to suffer from several associ- ated medical complications, such as renal … The prevalence of LEA in nonelderly diabetics with PAD (many of whom likely have end-stage renal disease

127. Comparative Effectiveness of Treatment for Hepatitis C in Adults | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hepatitis-c/research-protocol
     December 01, 2019 - according to patient subgroup characteristics, including but not limited to HCV genotype, age, race, sex, stage … harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … load, weight) Exclusions: pregnant women, HIV co-infection, transplant recipients, and patients with renal … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

128. Diabetes-Foot-Ulcer-Amputation-Incidence Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
     January 01, 2011 - amputation 2 People with diabetes often experience sev- eral associated medical complications, such as renal … The latter set of ICD-9 codes represents the following microvascular diseases: diabetic renal disease … Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population.

129. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - accepted the target serum uric acid (SUA) levels (as opposed to gout flare reduction) as their primary end-points … We have modified the text on use in renal impairment. … However, what is the stage before the acute arthritis stage? Asympotmatic hyperuricemia? … disease, and of intervening upon hyperuricemia demonstrating renal benefits. … These decisions were made at the Topic Refinement stage.

130. 1. What is the etiology of acute and chronic urinary retention in adults? 2. How do we define urinary retention (base case) including those with known neurologic problems? (aka What is considered abnormal PVR?) 3. What is the natural… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-what-is-the-etiology-of-acute-and-chronic-urinary-retention-in-adults-2-how-do-we-define-urinary-retention-base-case-including-those-with-known-neurologic-problems-aka-what-is-considered-abnormal-pvr-3-what-is-the-natural-
     November 01, 2017 - (For example, an ethnic group, stage or severity of a disease.) … Risk of infection Risk of renal failure, upper urinary tract deterioration, and urosepsis Risk of … with special health care needs, including individuals with disabilities or who need chronic care or end-of-life

131. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
     November 30, 2011 - harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … non-black); sex; stage of disease (e.g., cirrhosis or fibrosis); others (e.g., baseline viral load, … weight)  Exclusions: pregnant women, HIV co-infection, transplant recipients, and patients with renal … Key Informants Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

132. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
     February 01, 2013 - No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically … RLS is unknown, but the disorder also occurs secondary to other conditions such as iron deficiency, end-stage … No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically excluded … - Stage Renal Disease Requiring Hemodialysis Drug: Rotigotine; Placebo NCT00258492 RLS Syndrome … Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole Drug: ropinirole dosing

133. A total of 1,364 patients were treated with a neurothrombectomy device as part of X reports (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
     July 01, 2014 - Potential outcome measure by stage .................................................................. … Characteristics associated with ACP at various stages Stage of Health/Illness Healthy Potentially … domain: the interactive CD-ROM,32 the enhanced information aid,25 a Web site intervention in pilot stage … Potential outcome measure by stage Outcome Stage of Health / Illness Healthy Potentially Life Threatening … Paradigm Task Force Ottawa Patient Decision Aid Research Group PBS Religion & Ethics Newsweekly Renal

134. Disposition of Comments Report for Nitrous Oxide for the Management of Labor Pain (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
     August 23, 2012 - TENS is only used for first stage labor. … third stage boxes. … labor, length of second-stage labor, and length of third- stage labor. … Section Comment Response Reviewer #11 Results Biochemical Findings, p. 58: Since the main data are re renal … Footnotes are listed at the end of each table.

135. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stroke-atrial-fibrillation/research-protocol
     December 01, 2019 - We will monitor the number of articles excluded at the abstract stage for English language and determine … Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … At the full-text screening stage, two independent reviewers must agree on a final inclusion/exclusion … Key Informants Key Informants are the end-users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

136. Meeting Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
     January 01, 2011 - Collaborating with patient and consumer representatives at each stage in the research process improves … Toward that end, the expected role and required training of representatives should be clearly established … Presenting a clear timeline and anticipated time commitment at each stage of the project is also … Collyar President, Patient Advocates in Research (PAIR) Virna Elly Patient Advocate, Mid-Atlantic Renal

137. Vte-Prophyalaxis Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
     May 01, 2013 - failure, chronic renal failure, or end-stage renal disease. 22-25 Some of these patient groups have … impairment, or severe renal impairment not undergoing dialysis and patients receiving dialysis? … impairment, severe renal impairment, and renal replacement therapy (KQ 8) Special Populations (Timing … impairment, severe renal impairment, renal replacement therapy • Animal studies/models • Children … CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency.

138. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
     January 30, 2012 - We will monitor the number of articles excluded at the abstract stage for English language and determine … Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … At the full-text screening stage, two independent reviewers must agree on a final inclusion/exclusion … Key Informants Key Informants are the end-users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

139. Plasma-Cell-Dyscrasias-Sflc-Assay Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
     August 01, 2012 - Informants included representatives from the American Association for Clinical Chemistry; experts in renal … The other study, of C quality, compared the SFLC ratio with clinical stage (per Durie– Salmon staging … from already diagnosed patients could potentially bias the evidence, as they reflect the extreme end … reporting standards and a paucity of information regarding high-risk subgroups such as patients with renal … Serum free light chain measurements move to center stage.

140. Comparative Effectiveness Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - in 2-3 doses; Extended- release, 100-200 mg/day RA: Delayed- release, 100-200 mg/day in 3- 4 Renal … impairment(CrCl >25 mL/min) max 150 mg/day; Moderate renal impairment (CrCl l<25 mL/min) max 100 … (Give numbers at each stage of attrition.) … : No SS difference b/t lumiracoxib and NSAIDs for renal endpoint or serious liver AEs. … update 9/16/02 Pain reduction 2 placebo controlled trials provided pain intensity at baseline and end